GreenLight Biosciences Enters into Definitive Merger
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced...
Source: globenewswire.com
📰 Recommendation Statement News
Page 11 - Recommendation Statement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recommendation Statement. Real-time updates on events, politics, business and more.
Stratasys Board of Directors Unanimously Rejects Nano Dimension's Partial Tender Offer
Board of Directors Unanimously Recommends Stratasys Shareholders NOT Tender Shares into the Nano Tender Offer and Stresses Critical Importance for Stratasys Shareholders to Deliver a Notice of... | May 30, 2023
Yonah Lloyd Rosen Katz Exchange Commission Stratasys Ltd Growth Opportunities For The Combined Company Morrow Sodali
Source: marketscreener.com
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
LEXINGTON, Mass., May 30, 2023 -- GreenLight Biosciences Holdings, PBC today announced that the Company has entered into a definitive agreement to be acquired by a group of buyers led by Fall... | May 30, 2023
Source: marketscreener.com
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel...
United States Remy Bernarda Jenny Kobin Exchange Commission Cleopatra Acquisition Corp Biopharma Corp
Source: prnewswire.com
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
SEATTLE, May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. , a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related... | June 7, 2023
United States Jenny Kobin Remy Bernarda Exchange Commission Cleopatra Acquisition Corp Biopharma Corp
Source: marketscreener.com
Stratasys to Review Unsolicited Special Tender Offer From Nano Dimension
No Shareholder Action Required at this Time ... | May 25, 2023
Source: marketscreener.com
VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K
IRONWOOD PHARMACEUTICALS, INC. and VECTIVBIO HOLDING AG Dated as of May 21, 2023 TABLE... | May 23, 2023
Source: marketscreener.com
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
- Transaction Advances Ironwood’s Vision of Becoming the Leading GI Healthcare Company - - Adds apraglutide, Next Generation, Synthetic GLP-2 Analog in Phase 3 for Short Bowel Syndrome with... | May 22, 2023
United Kingdom United States Tom Mccourt Luca Santarelli Vectivbio Holding Ag Nasdaq Ironwood Pharmaceuticals Nasdaq
Source: marketscreener.com
Sobi to acquire CTI BioPharma Corp. enhancing Sobi's position in rare haematology
/PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) today announced that it has entered into an agreement and plan of merger with CTI...
Source: prnewswire.com
Sobi to Acquire CTI BioPharma | MarketScreener
Transaction Price of $9.10 Per Share Represents Compelling 89% Premium to CTIs Closing Stock Price on May 9, 2023 SEATTLE, May 10, 2023 /PRNewswire/ -- CTI BioPharma , a commercial... | May 10, 2023
Source: marketscreener.com